Gynazol 200mg Capsule contains Danazol, a synthetic steroid derivative with antigonadotropic and androgenic properties, indicated primarily for the management of endometriosis, fibrocystic breast disease, and hereditary angioedema. Danazol exerts its therapeutic effects by suppressing the mid-cycle surge of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), thereby reducing ovarian steroidogenesis and inducing a hypoestrogenic state. This mechanism helps alleviate symptoms associated with estrogen-dependent conditions, such as pelvic pain and abnormal bleeding in endometriosis. Additionally, Danazol stabilizes vascular permeability, making it effective in preventing attacks of hereditary angioedema. Gynazol 200mg should be administered under strict medical supervision, with dosage tailored to the individual patient’s condition and response. Common adverse effects include weight gain, acne, hirsutism, and menstrual irregularities, while more serious risks involve hepatic dysfunction and thromboembolic events, necessitating regular monitoring of liver function tests and hematological parameters. Gynazol is contraindicated in pregnancy, lactation, and patients with severe hepatic or renal impairment. Due to its androgenic activity, caution is advised in patients with cardiovascular disease or lipid abnormalities. This medication should be used as part of a comprehensive treatment plan, with periodic evaluation to assess efficacy and tolerability.